Cellebrite DI Ltd expected to post earnings of 9 cents a share - Earnings Preview

Cellebrite DI

04/11/2024 15:45

* Cellebrite DI Ltd  CLBT.OQ   CLBT.O  is expected to show a
rise
in quarterly revenue when it reports  results on November 6 for
the period ending September 30 2024
    * The Petah Tikva Israel-based   company is expected to
report a
21.1% increase in revenue to $101.929 million from $84.18
million a year ago, according to the mean estimate from 7
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Cellebrite DI Ltd is for
earnings of 9 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 2.3%
in the last three months. ​
    * Wall Street's median 12-month price target for Cellebrite
DI Ltd
is 20.00​, above​ its last closing price of $18.53. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  0.05        0.05       0.10      Beat    90.5
 Mar. 31 2024  0.05        0.06       0.08      Beat    42.9
 Dec. 31 2023  0.05        0.06       0.11      Beat    89.7​
 Sep. 30 2023  0.05        0.05       0.10      Beat    118.9
 ​​Jun.        0.02        0.02       0.05      Beat    114.3
 30 2023                                                
 Jan. 1 0001   0.02        0.02       0.04      Beat    77.8​
 Jan. 1 0001   0.03        0.04       0.08      Beat    
 Jan. 1 0001   0.02        0.02       0.01      Missed  -55.6
 This summary was machine generated November 4 at 15:44 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)